Low dose cytarabine monotherapy for myelodysplastic syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low dose cytarabine monotherapy for myelodysplastic syndromes

Published:2016-12-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bauer Kathrin¹,Hutzschenreuter Franz²,Skoetz Nicole²,Monsef Ina²,Kreuzer Karl-Anton³,Engert Andreas³

Affiliation:

1. Spitzenverband Bund der Krankenkassen; Reinhardtstraße 30 Berlin Germany 10117

2. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Cologne Germany

3. University Hospital of Cologne; Department I of Internal Medicine; Cologne Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference46 articles.

1. Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia;Alessandrino;American Journal of Hematology,1985

2. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology;Alessandrino;Haematologica,2002

3. Section: Antimetabolites;Allegra,1997

4. The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes;Aul;Cancer,1989

5. Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia;Baccarani;Leukemia Research,1983

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP